Loading...
Loading...

Go to the content (press return)

Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae (R) in adults with or without latent TB infection: safety and immunogenicity

Author
Montane, E.; Barriocanal, A.; Arellano, A.; Valderrama, A.; Sanz, Y.; Perez, N.; Cardona, P.; Vilaplana, C.
Type of activity
Journal article
Journal
PloS one
Date of publication
2017-02-09
Volume
12
Number
2
DOI
https://doi.org/10.1371/journal.pone.0171294 Open in new window
URL
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171294 Open in new window
Abstract
Background. Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in a murine experimental model that develop human-like lesions. Methods. Double-blind, randomized, placebo-controlled Clinical Trial (51 volunteers included). Two different doses of NR and a placebo were tested, the randomization was stratified by ...
Group of research
GRBIO - Biostatistics and Bioinformatics Research Group

Participants

  • Montane, Eva  (author)
  • Barriocanal, Ana Maria  (author)
  • Arellano, Ana Lucía  (author)
  • Valderrama, Angelica  (author)
  • Sanz Herranz, Yolanda  (author)
  • Perez Alvarez, Nuria  (author)
  • Cardona, Paula  (author)
  • Vilaplana, Cristina  (author)
  • Cardona, Pere-Joan  (author)